TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Paras Biopharmaceuticals Finland Oy
Closing information (x1000 SEK)
| Closing information | 2016/12 | 2015/12 | 2014/12 |
| Turnover |
191
|
566 | |
| Financial expenses |
163
|
46
|
10 |
| Earnings before taxes |
-8,830
|
-3,846
|
-2,645 |
| Total assets |
28,882
|
4,924
|
1,418 |
| Current assets |
19,478
|
713
|
209 |
| Current liabilities |
4,621
|
3,161
|
2,293 |
| Equity capital |
19,258
|
338
|
-1,227 |
| - share capital |
29
|
1,452
|
29 |
| Employees (average) | 15 |
Financial ratios
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Solvency |
66.7%
|
6.9%
|
-86.5% |
| Turnover per employee | 13 | ||
| Profit as a percentage of turnover |
-4623.0%
|
-679.5% | |
| Return on assets (ROA) |
-30.0%
|
-77.2%
|
-185.8% |
| Current ratio |
421.5%
|
22.6%
|
9.1% |
| Return on equity (ROE) |
-45.9%
|
-1137.9%
|
215.6% |
| Change turnover | -402 | ||
| Change turnover % | -68% | ||
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.